Navigation Links
Millennium Announces $200,000 Purchase Order From Greek Distributor
Date:4/1/2008

Nutrimedica, a Nutritional Distributor in Greece, to Purchase an Aggregate

of Over $200,000 of Resurgex(R) in 2008

BASKING RIDGE, N.J., April 1, 2008 /PRNewswire/ -- Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG), today reports the receipt of a $200,000 one year purchase order for the international distribution of the Resurgex(R) line in Greece. Millennium received the purchase order from Nutrimedica which is headquartered in Athens, Greece. Nutrimedica has served as Millennium's International Distribution Partner into Greece for the past two years. They have committed to purchase over $200,000 of Resurgex products for distribution into Greece in 2008.

This commitment to purchase over $200,000 of Resurgex(R) products for the Greek Market supported by a year to date purchase rate further enhances news released by Millennium in January of 2008 which reported overall sales in the Greek Market has increased from $30,000 in 2006 to $50,000 in 2007. These sales will now exceed $200,000 for 2008 which adds to the further expansion of Resurgex(R) product line into the international marketplace.

Nutrimedica has already imported and distributed Resurgex(R) products to hospitals, pharmacies, and direct to patients in Greece. Nutrimedica reports that the continued use of the Resurgex product line in Greece supports and encourages their expectation that the product line will be successful in the international marketplace.

Nutrimedica has been successful in broadening the usage of the Resurgex product line beyond Oncology, into other hospital settings including Intensive Care Units and Surgery Clinics.

About Millennium:

Millennium's six marketed products form the Company's advanced line of nutritional formulas. Resurgex Select(R) is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients
'/>"/>

SOURCE Millennium Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
2. Millennium Over-Delivers on 2007 Goals and Financial Guidance
3. Millennium Biotechnologies Group Reports 40% Sales Increase for Resurgex Product Line in Greek Market
4. Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
5. Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection
6. Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order
7. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
8. Millennium Research Group Offers New Marketrack Service that Tracks European Dental Implant Market
9. Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
10. Millennium to Webcast Third-Quarter 2007 Financial and Operational Results
11. Life Sciences Leader Joins Millennium Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , MANILA, Philippines, Dec. 2 /PRNewswire/ ...astest growing green energy companies on the plane...and True Green Planet,s President and Recycling Sp...ling business for over 25 years, stated that Spect...d is setting the stage for spectacular earnings be...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 ...rch report is available in its catalogue: ,, C...ive ,, http://www.reportlinker.com/p0164368/C...ive.html ,, Incubators are the most critical ...research, and other applications for providing a c...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire-USNewswire...tists, policy makers, and funders today convened t...ive funding strategies at the inaugural Partnerin...shington-based center of the Milken Institute, con...ector collaborations needed to turn a scientific d...
(Date:12/2/2009)..., , TUSTIN, Calif., Dec. 2 /PRNewswire-Fi...q: PPHM ) today reported completion of patient en...l of Cotara® in patients with relapsed gliobl...in cancer. Cotara is a targeted monoclonal antibo...otential new treatment for GBM. Cotara specifical...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...LOUIS, Jan. 8 Substantial progress and,momentum b...has Monsanto,(NYSE: MON ) poised to deliver sever...mpany leaders will tell investors today. The remar...on the company,s R&D pipeline in New,York and Bost...e pipeline right now," said,Steve Padgette, vice p...
...Initiative, Based on Advanced WiMAX Broadband Wire...s to Kindergartens, Elementary Schools and the ...CH TIKVA, Israel, January 8 012,Smile.Communicati... provider,of communication services in Israel, tod...stry of Communications, Intel Corporation (NYSE: ...
...SON, N.J., Jan. 7 Quest Diagnostics,Incorporated ...agnostic,testing, information and services, announ...al JPMorgan Healthcare Conference on Tuesday, Janu...isco, California. The Quest,Diagnostics presentati...e., The presentation will be webcast live during ...
Other Biology Technology:Monsanto's R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade 2Monsanto's R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade 3Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 2Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 3Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 4Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 5Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference 2
(Date:12/3/2009)...vels for the past three years in the troposphere (...area near Valladolid. The results, which are the f...that the levels rose "significantly" between 2002 ...teorologists have been trying to find out about ca...ved in the troposphere over various urban and rura...
(Date:12/3/2009)....S. Department of Energy,s (DOE) Brookhaven Nation...Institute of Science has made a major step in unde...tion in DNA that is necessary to carry out importa...n the December 1, 2009 edition of Nature Structur...ns responsible for interacting at specific sites o...
(Date:12/2/2009)...hand cigarette smoke have an increased risk of dev...er smoked. , Results of this study are publishe... , a journal of the American Association for Cance...the December issue. , This year alone, more tha...ncer; more than 159,000 will die from it and some ...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Grooving down the helix 2Grooving down the helix 3Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference 6021 1Approved lymphoma drug shows promise in early tests against bone cancer 60780 1Approved lymphoma drug shows promise in early tests against bone cancer 60780 2School Violence Drops With Federal Program 60777 1School Violence Drops With Federal Program 60777 2
...ut the quality of ingested food. It comprises five...itter, and umami stimuli. The possibility for an ...ten been suggested because many animals exhibit a ... of an actual sensor remained a matter of debate. ... the Journal of Clinical Investigation, Phillipe B...
... Harvard Medical School and Massachusetts Institut...European Cancer Conference (ECCO) have shown for t...ble using nanoparticle-apatamer conjugates. , Nuc...ort DNA or RNA fragments that can bind to target a...ous to monoclonal antibodies. In the field of canc...
... microorganisms living in the oceans, but the effe...hese microbes perform for the planet remains large...American Academy of Microbiology, entitled Marine ...ty. , "Since life most likely began in the oceans,...endants of the original forms of life," says Jenni...
Other Biology News:Researchers use 'trickery' to create immune response against melanoma 2Researchers use 'trickery' to create immune response against melanoma 3Researchers use 'trickery' to create immune response against melanoma 4Understanding the oceans microbes is key to the Earth's future 2
Sheep Anti-Human Factor XIII Antibody, Horseradish Peroxidase Conjugated from CEDARLANE Laboratories Limited
Mouse Anti-RYK Monoclonal Antibody, Unconjugated, Clone F30 P7 D7 F5 from Abcam
Rabbit Anti-E2F-5 Polyclonal Antibody, Unconjugated from Spring Bioscience
LAB/Probe Mouse-Rabbit DAB Kit - 500 Tests from Biomeda Corporation
Biology Products: